https://doi.org/10.22037/jcma.v1i1.10576

Tissues, Cells and Biomarkers in ARDS

authors:

avatar Seyed Mohammad Reza Hashemian 1 , * , avatar Makan Sadr 2 , avatar Ali Dabbagh ORCID 3

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Clinical Tuberculosis and EpidemiologyResearch Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Journal of Cellular & Molecular Anesthesia: Vol.1, issue 1; e150238
published online: December 22, 2015
article type: Letter to the Editor

How To Cite Hashemian S M R, Sadr M, Dabbagh A. Tissues, Cells and Biomarkers in ARDS. J Cell Mol Anesth. 2016;1(1):e150238. https://doi.org/10.22037/jcma.v1i1.10576.

Abstract

?The utility of biomarkers for the action of endothelium and epithelium of the pulmonary microvasculars is unknown and their action of being barrier for edema and dysfunction of them cause ARDS and its mortality rate with no specific drugs efficiency is high (1). Recently, there are many important information about biomarkers in ARDS (2). These biomarkers in ARDS can effect either cellular activation or cell injury. Currently, biomarkers are the most important research tool. The biomarkers have an important role in ARDS treatment in the function. There is an executive phase with some damage like edema and necroses. Then, fibro-proliferative phase will be happen. To understand the mechanism of repair, we focus on the function of alveolar type I (3). ?

References

  • 1.

    References are in the PDF file of the article.